Literature DB >> 20338426

Attitudes of Canadian dairy farmers toward a voluntary Johne's disease control program.

U Sorge1, D Kelton, K Lissemore, A Godkin, S Hendrick, S Wells.   

Abstract

The success of Johne's disease (JD) control programs based on risk assessment (RA) depends on producers' compliance with suggested management practices. One objective of this study was to describe the perception of participating Canadian dairy farmers of the impact of JD, the RA process, and suggested management strategies. The second objective was to describe the cost of changes in management practices following the RA. A telephone survey was conducted with 238 dairy farmers in Ontario, Manitoba, Saskatchewan, Alberta, and British Columbia. The producers agreed to participate in this follow-up study after they had been enrolled in an RA-based voluntary JD control program and had tested their herd with the JD milk ELISA test in 2005 to 2007. The majority of farms had no JD test-positive cows and, although some producers thought they had experienced the economic impact of JD, many did not see JD as a current problem for their herd. The majority of producers enrolled in this program because they were concerned that Mycobacterium avium ssp. paratuberculosis could be perceived by consumers as a cause for Crohn's disease in humans, which could lead to altered purchasing behavior of milk and milk products. Fifty-two farm-specific recommendations had been made after the initial RA. Although the producers generally liked the program and found the recommendations reasonable and feasible, on average only 2 of 6 suggestions made specifically to them were implemented. The recommendation with the highest compliance was culling of JD test-positive cows. The main reasons for noncompliance were that the dairy producer did not believe a change of management practices was necessary or the available barn setting or space did not allow the change. Producers were generally uncomfortable estimating time and monetary expenses for management changes, but found that several suggested management practices actually saved time and money. In addition, 39% of the producers that implemented at least 1 recommendation thought their calf and herd health had improved subsequently. This indicates that the communication of associated benefits needs to be improved to increase the compliance of producers with recommended management practices. Copyright (c) 2010 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20338426     DOI: 10.3168/jds.2009-2447

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  8 in total

1.  Adaptive Test Schemes for Control of Paratuberculosis in Dairy Cows.

Authors:  Carsten Kirkeby; Kaare Græsbøll; Søren Saxmose Nielsen; Lasse Engbo Christiansen; Nils Toft; Tariq Halasa
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

2.  Antibiotic Use on Goat Farms: An Investigation of Knowledge, Attitudes, and Behaviors of Missouri Goat Farmers.

Authors:  Lauren K Landfried; Ellen K Barnidge; Patrick Pithua; Roger D Lewis; Jonathan A Jacoby; Christopher C King; Carole R Baskin
Journal:  Animals (Basel)       Date:  2018-11-06       Impact factor: 2.752

Review 3.  Control of paratuberculosis: who, why and how. A review of 48 countries.

Authors:  Richard Whittington; Karsten Donat; Maarten F Weber; David Kelton; Søren Saxmose Nielsen; Suzanne Eisenberg; Norma Arrigoni; Ramon Juste; Jose Luis Sáez; Navneet Dhand; Annalisa Santi; Anita Michel; Herman Barkema; Petr Kralik; Polychronis Kostoulas; Lorna Citer; Frank Griffin; Rob Barwell; Maria Aparecida Scatamburlo Moreira; Iva Slana; Heike Koehler; Shoor Vir Singh; Han Sang Yoo; Gilberto Chávez-Gris; Amador Goodridge; Matjaz Ocepek; Joseba Garrido; Karen Stevenson; Mike Collins; Bernardo Alonso; Karina Cirone; Fernando Paolicchi; Lawrence Gavey; Md Tanvir Rahman; Emmanuelle de Marchin; Willem Van Praet; Cathy Bauman; Gilles Fecteau; Shawn McKenna; Miguel Salgado; Jorge Fernández-Silva; Radka Dziedzinska; Gustavo Echeverría; Jaana Seppänen; Virginie Thibault; Vala Fridriksdottir; Abdolah Derakhshandeh; Masoud Haghkhah; Luigi Ruocco; Satoko Kawaji; Eiichi Momotani; Cord Heuer; Solis Norton; Simeon Cadmus; Angelika Agdestein; Annette Kampen; Joanna Szteyn; Jenny Frössling; Ebba Schwan; George Caldow; Sam Strain; Mike Carter; Scott Wells; Musso Munyeme; Robert Wolf; Ratna Gurung; Cristobal Verdugo; Christine Fourichon; Takehisa Yamamoto; Sharada Thapaliya; Elena Di Labio; Monaya Ekgatat; Andres Gil; Alvaro Nuñez Alesandre; José Piaggio; Alejandra Suanes; Jacobus H de Waard
Journal:  BMC Vet Res       Date:  2019-06-13       Impact factor: 2.741

Review 4.  Veterinary Herd Health Consultancy and Antimicrobial Use in Dairy Herds.

Authors:  Nanna K Skjølstrup; Liza R Nielsen; Carsten S Jensen; Dorte B Lastein
Journal:  Front Vet Sci       Date:  2021-02-02

5.  Limitations in the implementation of control measures for bovine paratuberculosis in infected Swiss dairy and beef herds.

Authors:  Myriam Klopfstein; Alexandra Leyer; Beat Berchtold; Paul Robert Torgerson; Mireille Meylan
Journal:  PLoS One       Date:  2021-02-02       Impact factor: 3.240

6.  Sheep farmers' attitudes towards lameness control: Qualitative exploration of factors affecting adoption of the lameness Five-Point Plan.

Authors:  Caroline M Best; Alison Z Pyatt; Janet Roden; Malgorzata Behnke; Kate Phillips
Journal:  PLoS One       Date:  2021-02-09       Impact factor: 3.240

7.  Shedding patterns of dairy calves experimentally infected with Mycobacterium avium subspecies paratuberculosis.

Authors:  Rienske A R Mortier; Herman W Barkema; Karin Orsel; Robert Wolf; Jeroen De Buck
Journal:  Vet Res       Date:  2014-07-17       Impact factor: 3.683

8.  The effect of sub-clinical infection with Mycobacterium avium subsp. paratuberculosis on milk production in a New Zealand dairy herd.

Authors:  Andrew Bates; Rory O'Brien; Simon Liggett; Frank Griffin
Journal:  BMC Vet Res       Date:  2018-03-14       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.